Creative Biolabs Provides Abundant Recombinant Antibody Products Targeting at the Pancreatic Cancer

September 06 18:54 2019
Creative Biolabs possesses a large stock of comprehensive recombinant antibody products readily available for any projects concerning about the Pancreatic Cancer (PC), which can be delivered globally.

September 6, 2019 – New York, US –

An overview of Pancreatic Cancer

Pancreatic cancer, ranking third in cancer-related deaths in the United States, has been taken as one of the malignant tumors of the digestive system, marked with strong invasiveness, high degree of deterioration and low surgical resection rate. The 5-year survival rate of patients is lower than 5%, and the median survival time is only 5-6 months. As a result, optimizing early diagnosis and developing targeted therapy of pancreatic cancer seems crucial to improving the patients’ survival rate.

To accelerate the relevant research projects of pancreatic cancer, Creative Biolabs supplies a full set of regarding antibody products to meet urgent needs in the research and medicine manufacturing field. The products served can be applied in the most significant processes of cancer development behaviors, i.e. signaling cascades, of which the key ones include RTK pathway, JNK signaling pathway, TGF-β/SMAD pathway, Wnt signaling pathway, SHH pathway and Notch signaling pathway, which function by means of targeting at the molecular markers of PC. The two key products hold the following information and features.

KRAS antibodies

From hosts like mouse, rabbit and rat, the KARS antibody products target at the Kristen ras oncogene homolog, whose amino acid involves in mutation activation. The abundant products have broad applications in the Immunohistochemistry-Frozen Sections (C), Immunofluorescence (IF) and Western Blot (WB), and so on, with various antibody isotypes like IgG, IgG1, and IgG2 which assist with isotype control in customers’ projects. Both antibody and antigen types are accessible at Creative Biolabs for selection.

SHH antibodies

With similar hosts, the anti-SHH products targeting at the gene SHH that is significant in patterning the early embryo. Deficiencies in such gene or in the sonic hedgehog signaling pathway may result in holoprosencephaly (HPE). Served to be applied in a variety of labs and catering to experiment conditions, the SHH antibodies from Creative Biolabs cross-react in mammals, amphibians birds and fishes, specifically human and NHP, African clawed frog, chicken and quail, and zebrafish. There is only one rule to obey, that is, to store the products at +4°C short-term (1-2 weeks), and aliquot and store at -20°C long-term. Avoid repeated freeze/thaw cycles.

“We always keep our eyes on the cancer therapy development,” according to the head of Creative Biolabs, who has been dedicated in the field of more than 20 years. Pancreatic adenocarcinoma occupies around 85% of PC cases. The biomarker targeting therapies of PC is gaining ascending attention. Creative Biolabs wishes to make every effort to accelerate relevant projects with its recombinant products.

For more details about the antibodies, please visit

About the Company

Since 2004, Creative Biolabs has been dedicated to providing high-quality services in academic and life science worldwide, and has received many successes in discovering and manufacturing recombinant antibodies. In Creative Biolabs, advanced antibody research tools, professional technical support, and rapid global delivery are guarantees for scientific research workers and customers in industry.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States